In addition, Loo has a deemed interest in another 783.8 million shares, giving him a total interest of 984.35 million shares, or 53.138%.
Earlier on Aug 1, Raffles Medical reported revenue of $382 million for 1HFY2022 ended June, up 11% y-o-y, as foreign patients returned. However, thanks to better margins, the company was able to report that earnings increased by 51% y-o-y to a record $60 million.
Local patients have also returned, choosing to undergo elective procedures previously held back because of the pandemic.
Raffles Medical for the better part of FY2021, enjoyed a lift from providing pandemic-related testing and vaccination services, which had since tapered off.
See also: Ho Bee Land’s executive director and CEO Nicholas Chua ups stake in company
Raffles Medical's shares closed on Aug 2 at $1.25, up 4.17% for the day but down 8.09% year to date.
